Lessons From The Pfizer Off-Label Settlement: Compliance Programs Not Enough To Demonstrate Integrity, DOJ Says
Executive Summary
A lesson of Pfizer's $2.3 billion corporate integrity settlement with the Department of Justice is that good integrity policies are meaningless without employee adherence, according to government attorneys